Form 4 for PROP Prairie Operating Co.
Accepted 2024-09-18 00:00:00 ET · period of report 2023-09-07 · accession 0001140361-24-041384 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-09-18 | 2024-05-01 | PROP | Wallis James W. | 10% | X - OptEx | $6.00 | +63.7K | 769.9K | +9% | +$382.3K |
| DI | 2024-09-18 | 2023-09-07 | PROP | Wallis James W. | 10% | P - Purchase | $3.05 | +204.4K | 774.3K | +36% | +$623.5K |
| DI | 2024-09-18 | 2023-10-10 | PROP | Wallis James W. | 10% | S - Sale+OE | $3.05 | -68.1K | 706.2K | -9% | -$207.8K |
| DMI | 2024-09-18 | 2023-09-07 | PROP | Wallis James W. | 10% | P - Purchase | $3.05 | +191.6K | 477.89 | New | +$584.5K |
| DMI | 2024-09-18 | 2023-10-10 | PROP | Wallis James W. | 10% | S - Sale | $3.05 | -63.9K | 318.59 | -100% | -$194.8K |
| DI | 2024-09-18 | 2024-05-01 | PROP | Wallis James W. | 10% | X - OptEx | $0.00 | -63.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-01 | X | A | 63,719 | $6.00 | 769,930 | I By James W Wallis Living Trust | — | — | (F2) On October 16, 2023, the issuer effected a reverse stock split of the outstanding shares of the issuer's common stock at an exchange ratio of 1:28.5714286. All security amounts and conversion prices have been adjusted to reflect this reverse stock split. |
| 2 | Common | Common Stock | 2023-09-07 | P | A | 204,422 | $3.05 | 774,345 | I By James W. Wallis LivingTrust | — | — | (F1) On September 7, 2023, the Reporting Person Purchased for a purchase price of $1.5 million, the following securities: 204,222 shares of Common Stock; 477.89 shares of Series D Convertible Preferred Stock; 95,578 Series A Warrants; and 95,578 Series B Warrants. The values of the aforementioned securities were adjusted to reflect the reverse stock split that occurred on October 16, 2023. (F2) On October 16, 2023, the issuer effected a reverse stock split of the outstanding shares of the issuer's common stock at an exchange ratio of 1:28.5714286. All security amounts and conversion prices have been adjusted to reflect this reverse stock split. |
| 3 | Common | Common Stock | 2023-10-10 | S | D | 68,134 | $3.05 | 706,211 | I By James W. Wallis Living Trust | — | — | (F3) On October 10, 2023, the Reporting Person sold for $500,000, the following securities: 68,134 shares of Common Stock; 159.30 shares of Series D Convertible Preferred Stock; 31,860 Series A Warrants; and 31,860 Series B Warrants. (F2) On October 16, 2023, the issuer effected a reverse stock split of the outstanding shares of the issuer's common stock at an exchange ratio of 1:28.5714286. All security amounts and conversion prices have been adjusted to reflect this reverse stock split. |
| 4 | Derivative | Series A Warrants | 2023-09-07 | P | A | 95,578 | $3.05 | 95,578 | I By: James W. Wallis Living Trust | $6.00 · 2023-05-03 to 2028-05-03 | 95,578 Common Stock | (F1) On September 7, 2023, the Reporting Person Purchased for a purchase price of $1.5 million, the following securities: 204,222 shares of Common Stock; 477.89 shares of Series D Convertible Preferred Stock; 95,578 Series A Warrants; and 95,578 Series B Warrants. The values of the aforementioned securities were adjusted to reflect the reverse stock split that occurred on October 16, 2023. (F2) On October 16, 2023, the issuer effected a reverse stock split of the outstanding shares of the issuer's common stock at an exchange ratio of 1:28.5714286. All security amounts and conversion prices have been adjusted to reflect this reverse stock split. |
| 5 | Derivative | Series B Warrants | 2023-09-07 | P | A | 95,578 | $3.05 | 95,578 | I By: James W. Wallis Living Trust | $6.00 · 2023-05-03 to 2024-05-03 | 95,578 Common Stock | (F1) On September 7, 2023, the Reporting Person Purchased for a purchase price of $1.5 million, the following securities: 204,222 shares of Common Stock; 477.89 shares of Series D Convertible Preferred Stock; 95,578 Series A Warrants; and 95,578 Series B Warrants. The values of the aforementioned securities were adjusted to reflect the reverse stock split that occurred on October 16, 2023. (F2) On October 16, 2023, the issuer effected a reverse stock split of the outstanding shares of the issuer's common stock at an exchange ratio of 1:28.5714286. All security amounts and conversion prices have been adjusted to reflect this reverse stock split. |
| 6 | Derivative | Series A Warrants | 2023-10-10 | S | D | 31,860 | $3.05 | 63,719 | I By: James W. Wallis Living Trust | $6.00 · 2023-05-03 to 2028-05-03 | 31,860 Common Stock | (F3) On October 10, 2023, the Reporting Person sold for $500,000, the following securities: 68,134 shares of Common Stock; 159.30 shares of Series D Convertible Preferred Stock; 31,860 Series A Warrants; and 31,860 Series B Warrants. (F2) On October 16, 2023, the issuer effected a reverse stock split of the outstanding shares of the issuer's common stock at an exchange ratio of 1:28.5714286. All security amounts and conversion prices have been adjusted to reflect this reverse stock split. |
| 7 | Derivative | Series B Warrants | 2023-10-10 | S | D | 31,860 | $3.05 | 63,719 | I By: James W. Wallis Living Trust | $6.00 · 2023-05-03 to 2024-05-03 | 31,860 Common Stock | (F3) On October 10, 2023, the Reporting Person sold for $500,000, the following securities: 68,134 shares of Common Stock; 159.30 shares of Series D Convertible Preferred Stock; 31,860 Series A Warrants; and 31,860 Series B Warrants. (F2) On October 16, 2023, the issuer effected a reverse stock split of the outstanding shares of the issuer's common stock at an exchange ratio of 1:28.5714286. All security amounts and conversion prices have been adjusted to reflect this reverse stock split. |
| 8 | Derivative | Series D Convertible Preferred Stock | 2023-09-07 | P | A | 477.89 | $3.05 | 477.89 | I By: James W. Wallis Living Trust | $5.00 · 2023-05-03 to — | 95,578 Common Stock | (F1) On September 7, 2023, the Reporting Person Purchased for a purchase price of $1.5 million, the following securities: 204,222 shares of Common Stock; 477.89 shares of Series D Convertible Preferred Stock; 95,578 Series A Warrants; and 95,578 Series B Warrants. The values of the aforementioned securities were adjusted to reflect the reverse stock split that occurred on October 16, 2023. (F4) The shares of Series D Convertible Preferred Stock have no expiration date. |
| 9 | Derivative | Series B Warrants | 2024-05-01 | X | D | 63,719 | $0.00 | 0 | I By: James W. Wallis Living Trust | $6.00 · 2023-05-03 to 2024-05-03 | 63,719 Common Stock | (F2) On October 16, 2023, the issuer effected a reverse stock split of the outstanding shares of the issuer's common stock at an exchange ratio of 1:28.5714286. All security amounts and conversion prices have been adjusted to reflect this reverse stock split. |
| 10 | Derivative | Series D Convertible Preferred Stock | 2023-10-10 | S | D | 159.30 | $3.05 | 318.59 | I By: James W. Wallis Living Trust | $5.00 · 2023-05-03 to — | 31,860 Common Stock | (F3) On October 10, 2023, the Reporting Person sold for $500,000, the following securities: 68,134 shares of Common Stock; 159.30 shares of Series D Convertible Preferred Stock; 31,860 Series A Warrants; and 31,860 Series B Warrants. (F4) The shares of Series D Convertible Preferred Stock have no expiration date. |